These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 8740003)

  • 1. Analysis for recovery and loss of mononuclear cells and colony-forming units granulocyte-macrophage during ex vivo processing of autologous bone marrow.
    Schwella N; Heuft HG; Rick O; Blasczyk R; Wittmann G; Huhn D
    Vox Sang; 1996; 70(3):132-8. PubMed ID: 8740003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of autologous bone marrow grafts for cryopreservation using the AS104 cell separator.
    Rick O; Heuft HG; Wittmann G; Blasczyk R; Huhn D; Schwella N
    J Clin Apher; 1997; 12(4):179-82. PubMed ID: 9483179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow mononuclear cell count does not predict neutrophil and platelet recovery following autologous bone marrow transplant: value of the colony-forming unit granulocyte-macrophage (CFU-GM) assay.
    al-Fiar F; Prince HM; Imrie K; Stewart AK; Crump M; Keating A
    Cell Transplant; 1997; 6(5):491-5. PubMed ID: 9331500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
    Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
    Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mononuclear cell dose of 3 x 10(8)/kg predicts early multilineage recovery in patients with malignant lymphoma treated with carmustine, etoposide, Ara-C and melphalan (BEAM) and peripheral blood progenitor cell transplantation.
    Smith RJ; Sweetenham JW
    Exp Hematol; 1995 Dec; 23(14):1581-8. PubMed ID: 8542950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CFU-GM content of bone marrow graft correlates with time to hematologic reconstitution following autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged bone marrow.
    Rowley SD; Zuehlsdorf M; Braine HG; Colvin OM; Davis J; Jones RJ; Saral R; Sensenbrenner LL; Yeager A; Santos GW
    Blood; 1987 Jul; 70(1):271-5. PubMed ID: 3297203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
    Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow reconstitution after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: effect of graft size.
    van der Wall E; Richel DJ; Holtkamp MJ; Slaper-Cortenbach IC; van der Schoot CE; Dalesio O; Nooijen WJ; Schornagel JH; Rodenhuis S
    Ann Oncol; 1994 Nov; 5(9):795-802. PubMed ID: 7531486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of infused CFU-GM and CFU-Mk mobilized by chemotherapy with or without G-CSF to platelet recovery after autologous blood stem cell transplantation.
    Takamatsu Y; Harada M; Teshima T; Makino S; Inaba S; Akashi K; Shibuya T; Niho Y
    Exp Hematol; 1995 Jan; 23(1):8-13. PubMed ID: 7527786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery of CFU-GM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment.
    Douay L; Gorin NC; Mary JY; Lemarie E; Lopez M; Najman A; Stachowiak J; Giarratana MC; Baillou C; Salmon C
    Exp Hematol; 1986 Jun; 14(5):358-65. PubMed ID: 3519263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GM-CSF therapy for delayed engraftment after autologous bone marrow transplantation.
    Brandwein JM; Nayar R; Baker MA; Sutton DM; Scott JG; Sutcliffe SB; Keating A
    Exp Hematol; 1991 Mar; 19(3):191-5. PubMed ID: 1995310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion cultures.
    Koller MR; Emerson SG; Palsson BO
    Blood; 1993 Jul; 82(2):378-84. PubMed ID: 8329697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separation of mononuclear bone marrow cells using the Cobe 2997 blood cell separator.
    Faradji A; Andreu G; Pillier-Loriette C; Bohbot A; Nicod A; Autran B; Bergerat JP; Rio B; Leblond V; Binet JL
    Vox Sang; 1988; 55(3):133-8. PubMed ID: 3070937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined use of growth factors to stimulate the proliferation of hematopoietic progenitor cells after autologous bone marrow transplantation for lymphoma patients.
    Lemoli RM; Fortuna A; Fogli M; Rosti G; Gherlinzoni F; Visani G; Catani L; Gozzetti A; Tura S
    Acta Haematol; 1996; 95(3-4):164-70. PubMed ID: 8677737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progenitor content of autologous grafts: mobilized bone marrow vs mobilized blood.
    Dahl E; Burroughs J; DeFor T; Verfaillie C; Weisdorf D
    Bone Marrow Transplant; 2003 Sep; 32(6):575-80. PubMed ID: 12953129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The collection and evaluation of peripheral blood progenitor cells sufficient for repetitive cycles of high-dose chemotherapy support.
    Benjamin RJ; Linsley L; Axelrod JD; Churchill WH; Sieff C; Shulman LN; Elias A; Ayash L; Malachowski ME; Uhl L
    Transfusion; 1995 Oct; 35(10):837-44. PubMed ID: 7570914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte-monocyte colony forming unit content of autologous bone marrow transplants in patients with haematological malignancy.
    Petrovecki M; Nemet D; Kolevska T; Marusić M
    Eur J Clin Chem Clin Biochem; 1995 Oct; 33(10):687-91. PubMed ID: 8608188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts.
    Rowley SD; Piantadosi S; Marcellus DC; Jones RJ; Davidson NE; Davis JM; Kennedy J; Wiley JM; Wingard JR; Yeager AM
    Bone Marrow Transplant; 1991 Mar; 7(3):183-91. PubMed ID: 2059755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cell concentration on bone marrow and peripheral blood stem cell cryopreservation.
    Rowley SD; Bensinger WI; Gooley TA; Buckner CD
    Blood; 1994 May; 83(9):2731-6. PubMed ID: 7513212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.